Literature DB >> 16159629

IL-4-expressing bronchoalveolar T cells from asthmatic and healthy subjects preferentially express CCR 3 and CCR 4.

Angela J Morgan1, Fiona A Symon, Mike A Berry, Ian D Pavord, Christopher J Corrigan, Andrew J Wardlaw.   

Abstract

BACKGROUND: The concept of the polarization of chemokine receptor expression by T(H)1 and T(H)2 cells provides an attractive mechanism for their differential recruitment to tissue, which could be subject to disease-specific therapeutic intervention. The paradigm that T(H)1 cells preferentially express CXCR 3 and CCR 5 and T(H)2 cells preferentially express CCR 3, CCR 4, and CCR 8 has been well established in the setting of in vitro polarized cell lines; however, the situation in vivo appears less clear-cut.
OBJECTIVE: We sought to investigate whether this pattern of polarization can be demonstrated in human lung tissue.
METHODS: We used single-cell analysis to investigate the relationship between chemokine receptor expression and cytokine production on peripheral blood and bronchoalveolar lavage fluid T cells in patients with asthma, a putative T(H)2 disease, as well as in healthy control subjects.
RESULTS: We have found in both asthmatic and control subjects that IL-4-expressing blood and bronchoalveolar lavage fluid T cells are significantly more likely to express the T(H)2 type 2 chemokine receptors CCR 3 and CCR 4, with 10-fold and 2-fold differences in expression, respectively, compared with IFN-gamma-expressing cells.
CONCLUSION: We have provided evidence that polarization of T(H)2-type chemokine receptors on IL-4-expressing cells can be demonstrated in an in vivo setting and therefore that these cells might indeed be susceptible to differential patterns of recruitment as a result of expression of the relevant chemokines at inflammatory sites.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16159629     DOI: 10.1016/j.jaci.2005.03.052

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  18 in total

Review 1.  Chemokines and their receptors as potential targets for the treatment of asthma.

Authors:  C Palmqvist; A J Wardlaw; P Bradding
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

2.  A role for CCL28-CCR3 in T-cell homing to the human upper airway mucosa.

Authors:  E Danilova; I Skrindo; E Gran; B J Hales; W A Smith; J Jahnsen; F E Johansen; F L Jahnsen; E S Baekkevold
Journal:  Mucosal Immunol       Date:  2014-06-11       Impact factor: 7.313

3.  Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma.

Authors:  Mike Berry; Angela Morgan; Dominick E Shaw; Deborah Parker; Ruth Green; Christopher Brightling; Peter Bradding; Andrew J Wardlaw; Ian D Pavord
Journal:  Thorax       Date:  2007-03-13       Impact factor: 9.139

4.  Expression of CCR8 is increased in asthma.

Authors:  K Mutalithas; C Guillen; C Raport; R Kolbeck; D Soler; C E Brightling; I D Pavord; A J Wardlaw
Journal:  Clin Exp Allergy       Date:  2010-04-28       Impact factor: 5.018

5.  The airway smooth muscle CCR3/CCL11 axis is inhibited by mast cells.

Authors:  R Saunders; A Sutcliffe; L Woodman; D Kaur; S Siddiqui; Y Okayama; A Wardlaw; P Bradding; C Brightling
Journal:  Allergy       Date:  2008-09       Impact factor: 13.146

6.  Targeted reduction of CCR4⁺ cells is sufficient to suppress allergic airway inflammation.

Authors:  Akifumi Honjo; Hirohisa Ogawa; Masahiko Azuma; Toshifumi Tezuka; Saburo Sone; Arya Biragyn; Yasuhiko Nishioka
Journal:  Respir Investig       Date:  2013-06-22

7.  Airway hyperresponsiveness is dissociated from airway wall structural remodeling.

Authors:  Salman Siddiqui; Vijay Mistry; Camille Doe; Katy Roach; Angela Morgan; Andrew Wardlaw; Ian Pavord; Peter Bradding; Christopher Brightling
Journal:  J Allergy Clin Immunol       Date:  2008-06-24       Impact factor: 10.793

8.  Chemokine responsiveness of CD4+ CD25+ regulatory and CD4+ CD25- T cells from atopic and nonatopic donors.

Authors:  D Ahern; C M Lloyd; D S Robinson
Journal:  Allergy       Date:  2009-02-07       Impact factor: 13.146

9.  T lymphocytes expressing CCR3 are increased in allergic rhinitis compared with non-allergic controls and following allergen immunotherapy.

Authors:  J N Francis; C M Lloyd; I Sabroe; S R Durham; S J Till
Journal:  Allergy       Date:  2007-01       Impact factor: 13.146

Review 10.  What does elevated TARC/CCL17 expression tell us about eosinophilic disorders?

Authors:  Julien Catherine; Florence Roufosse
Journal:  Semin Immunopathol       Date:  2021-05-19       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.